This is Kate's original diagnosed cancer type - treatable, not curable ie ..bluntly ... it will ultimately kill her/she'll die of it ...
BUT ..... if someone where to decide to fake cancer, Metastatic ALK-Rearrangement Positive Non-Small Cell Lung Cancer, like Kate had/has, is certainly one that has a long life expectancy .... just saying ..... I'm not a Doctor, after all ... and the same can be said for the T4NxM1c (Stage IVB) Adenocarcinoma that she was diagnosed with in 2023 ....
Is Metastatic ALK-Rearrangement Positive Non-Small Cell Lung Cancer (NSCLC) Curable?
No, metastatic ALK-positive NSCLC is not considered curable, but it is highly treatable, and many patients live for years with modern targeted therapies. Unlike other stage 4 lung cancers, ALK-positive NSCLC responds exceptionally well to ALK inhibitors, significantly extending survival.
1. Why Isn’t It Considered Curable?
Metastatic (stage 4) lung cancer means that the cancer has spread beyond the lungs (e.g., to the brain, liver, bones, or lymph nodes).
2. Can Long-Term Remission Be Achieved?
- In stage 4 cancer, even if the visible tumors shrink or disappear, microscopic cancer cells usually remain somewhere in the body, leading to eventual recurrence.
- No current treatment eliminates all ALK-positive cancer cells permanently.
Yes, some patients achieve long-term remission (No Evidence of Disease – NED), but this is not the same as a cure because the cancer can eventually return.
ALK inhibitors (like alectinib, brigatinib, lorlatinib) can control the disease for many years.
Some patients live 8-10+ years with treatment, but the cancer almost always develops resistance at some point.
3. How Do ALK-Positive NSCLC Patients Live Longer Than Other Stage 4 Lung Cancer Patients?
ALK inhibitors (targeted therapy) work extremely well, often shrinking tumors by 50-80% and keeping the disease stable for years.
Newer ALK inhibitors (like lorlatinib) help overcome resistance, giving patients multiple lines of treatment.
Radiation (SRS) for brain metastases + ALK inhibitors can keep the disease under control for longer.
4. What Could Lead to a Cure in the Future?
5. Final Verdict: Treatable but Not Curable
- Next-generation ALK inhibitors that delay or prevent resistance.
- Combination therapies (e.g., ALK inhibitors + immunotherapy or chemotherapy).
- Early-stage detection before metastasis occurs.
Metastatic ALK-positive NSCLC is NOT curable with current treatments.
However, it is one of the most treatable forms of stage 4 lung cancer, with some patients surviving 8-10+ years.
Ongoing research may eventually lead to a cure, but for now, the goal is long-term disease control and quality of life.
In addition
Many ALK+ patients stay in NED for 3-5 years on Alectinib alone.
With multiple ALK inhibitors and careful treatment, some patients reach 8-10+ years of survival.
NED is not the same as a cure, but long-term survival is possible.
Regular scans and molecular testing help doctors switch treatments before major progression occurs.
I do believe she has cancer and this has definitely cemented for me that western medicine and the ALK inhibitors are keeping her alive and even giving her the NED results. I really appreciate how clear the ChatGPT response is as this has answered a lot of my questions about how someone in stage 4 can achieve NED or even no growth/shrinkage of tumours. I also think the response regarding differences between scans have helped. I think Kate has leveraged clear scans but doesn't explain which ones would be helpful for her particular condition, namely because a) she fundamentally has not even researched or even understood her own disease and b) likes to use double-speak and talk absolute circles thinking what she does in terms of treatments sounds impressive. How would a lay person know she wouldn't have ultrasound? Or the fact that if they use that at H4C it could plausibly give people a false impression?
H4C is such a scam and I cannot believe she is directing people to that place.